-
2021년 표적치료연구회 추계학술대회
일시 : 2021년 10월 29일 (금)
장소 : 서울 밀레니엄힐튼호텔, 지하 1층 그랜드볼룸
연수평점 : 6점
사회: 오인재 (표적치료연구회 총무)
| Time | Title | Speaker & Chairperson |
|---|---|---|
| 10:20 ~ 10:55 | Registration | |
| 10:55 ~ 11:00 | Opening address | 류정선 (표적치료연구회장) |
| 11:00 ~ 12:30 | Session I. Perspective of current lung cancer study |
류정선 (인하의대), 신경철 (영남의대) |
| 11:00 ~ 11:30 | 수월성이 확보된 연구를 위한 제언 | 박헌주 (인하의대) |
| 11:30 ~ 12:00 | 3D Cancer Genome: A new method to predict the functional consequences of structural variation | 정인경 (KAIST) |
| 12:00 ~ 12:30 | TME of early lung adenocarcinoma from non-smokers and its usefulness as a therapeutic target | 장윤수 (연세의대) |
| 12:30 ~ 13:30 | Luncheon |
장승훈 (한림의대) |
| Synergy of IO/IO combination in NSCLC 1L and Mesothelioma 1L | 박순효 (계명의대) | |
| 13:30 ~ 15:00 | Session II. Exosome-based liquid biopsy in lung cancer |
이계영 (건국의대), 김영철 (전남의대) |
| 13:30 ~ 14:00 | Isolation and characterization of extracellular vesicles | 박재성 (포항공대) |
| 14:00 ~ 14:30 | Next Generation Proteomics of Extracelullar Vesicles in Lung Adenocarcinoma | 백제현 ((재)씨젠의료재단)) |
| 14:30 ~ 15:00 | Exosome-based BALiquid EGFR genotyping in real world practice | 김희정 (건국의대) |
| 15:00 ~ 15:30 | Coffee Break | |
| 15:30 ~ 17:00 | Session III. Lung Cancer Diagnosis: Present and future |
하승연 (가천의대), 김승준 (가톨릭의대) |
| 15:30 ~ 16:00 | Current status and updates of lung cancer diagnosis in Korea | 김루시아 (인하의대) |
| 16:00 ~ 16:30 | Evolution of lung cancer and its clinical implication: A pathologist’s view | 이옥준 (충북의대) |
| 16:30 ~ 17:00 | Digital pathology: Current status and future direction | 장혜윤 (딥바이오) |
| 17:00 ~ 17:30 | 추계학술연구비 숙제보고 및 연구비 시상 |
|
| 17:00 ~ 17:15 | Identification of the role of regulatory T cell as predictive biomarker for e cacy of immune checkpoint blockade in lung cancer | 이정은 (충남의대) |
| 17:15 ~ 17:30 | Afatinib mediates autophagic degradation of ORAI1, STIM1, and SERCA2, which inhibits proliferation of non-small cell lung cancer cells | 양세훈 (원광의대) |
| 17:40 |
Closing | |